Canada Life’s Veradigm Inc. Common Stock MDRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-104,687
| Closed | -$1.1M | – | 2166 |
|
|
2023
Q4 | $1.1M | Sell |
104,687
-7,097
| -6% | -$87K | ﹤0.01% | 1483 |
|
|
2023
Q3 | $1.47M | Sell |
111,784
-728
| -0.6% | -$9.55K | ﹤0.01% | 1347 |
|
|
2023
Q2 | $1.42M | Sell |
112,512
-7,671
| -6% | -$93.2K | ﹤0.01% | 1363 |
|
|
2023
Q1 | $1.57M | Sell |
120,183
-6,857
| -5% | -$111K | ﹤0.01% | 1344 |
|
|
2022
Q4 | $2.24M | Sell |
127,040
-10,550
| -8% | -$177K | 0.01% | 1179 |
|
|
2022
Q3 | $2.09M | Buy |
137,590
+22,610
| +20% | +$366K | 0.01% | 1150 |
|
|
2022
Q2 | $1.7M | Buy |
114,980
+9,057
| +9% | +$169K | ﹤0.01% | 1219 |
|
|
2022
Q1 | $2.45M | Buy |
105,923
+17
| +0% | +$344 | 0.01% | 1103 |
|
|
2021
Q4 | $1.95M | Sell |
105,906
-1,924
| -2% | -$30.6K | ﹤0.01% | 1210 |
|
|
2021
Q3 | $1.45M | Sell |
107,830
-14,885
| -12% | -$240K | ﹤0.01% | 1356 |
|
|
2021
Q2 | $2.27M | Buy |
122,715
+2,108
| +2% | +$35.5K | 0.01% | 1074 |
|
|
2021
Q1 | $1.81M | Sell |
120,607
-35,443
| -23% | -$568K | ﹤0.01% | 1216 |
|
|
2020
Q4 | $2.25M | Sell |
156,050
-27,137
| -15% | -$328K | ﹤0.01% | 1075 |
|
|
2020
Q3 | $1.49M | Sell |
183,187
-17,684
| -9% | -$144K | ﹤0.01% | 1215 |
|
|
2020
Q2 | $1.36M | Buy |
200,871
+115,450
| +135% | +$748K | ﹤0.01% | 1268 |
|
|
2020
Q1 | $600K | Buy |
85,421
+5,465
| +7% | +$44.3K | ﹤0.01% | 1533 |
|
|
2019
Q4 | $778K | Buy |
+79,956
| New | +$842K | ﹤0.01% | 1592 |
|
|
2019
Q3 | – | Sell |
-105,315
| Closed | -$1.23M | – | 2421 |
|
|
2019
Q2 | $1.23M | Hold |
105,315
| – | – | ﹤0.01% | 1442 |
|
|
2019
Q1 | $1M | Hold |
105,315
| – | – | ﹤0.01% | 1380 |
|
|
2018
Q4 | $943K | Hold |
105,315
| – | – | ﹤0.01% | 1420 |
|
|
2018
Q3 | $1.5M | Hold |
105,315
| – | – | ﹤0.01% | 1349 |
|
|
2018
Q2 | $1.26M | Sell |
105,315
-5,500
| -5% | -$67.8K | ﹤0.01% | 1437 |
|
|
2018
Q1 | $1.37M | Buy |
110,815
+1,800
| +2% | +$25.6K | ﹤0.01% | 1367 |
|
|
2017
Q4 | $1.58M | Buy |
109,015
+6,438
| +6% | +$89.4K | ﹤0.01% | 1307 |
|
|
2017
Q3 | $1.46M | Sell |
102,577
-3,103
| -3% | -$40.1K | ﹤0.01% | 1353 |
|
|
2017
Q2 | $1.35M | Hold |
105,680
| – | – | ﹤0.01% | 1390 |
|
|
2017
Q1 | $1.34M | Buy |
105,680
+3,387
| +3% | +$40.2K | ﹤0.01% | 1363 |
|
|
2016
Q4 | $1.04M | Sell |
102,293
-11,363
| -10% | -$130K | ﹤0.01% | 1465 |
|
|
2016
Q3 | $1.5M | Buy |
113,656
+6,335
| +6% | +$84.7K | ﹤0.01% | 1235 |
|
|
2016
Q2 | $1.36M | Buy |
107,321
+89,893
| +516% | +$1.19M | ﹤0.01% | 1251 |
|
|
2016
Q1 | $230K | Hold |
17,428
| – | – | ﹤0.01% | 1233 |
|
|
2015
Q4 | $268K | Hold |
17,428
| – | – | ﹤0.01% | 1137 |
|
|
2015
Q3 | $217K | Hold |
17,428
| – | – | ﹤0.01% | 1206 |
|
|
2015
Q2 | $238K | Hold |
17,428
| – | – | ﹤0.01% | 1286 |
|
|
2015
Q1 | $208K | Hold |
17,428
| – | – | ﹤0.01% | 1330 |
|
|
2014
Q4 | $222K | Hold |
17,428
| – | – | ﹤0.01% | 1253 |
|
|
2014
Q3 | $235K | Buy |
17,428
+6,000
| +53% | +$90.9K | ﹤0.01% | 1158 |
|
|
2014
Q2 | $183K | Buy |
11,428
+4,306
| +60% | +$67.1K | ﹤0.01% | 1183 |
|
|
2014
Q1 | $128K | Hold |
7,122
| – | – | ﹤0.01% | 1312 |
|
|
2013
Q4 | $111K | Hold |
7,122
| – | – | ﹤0.01% | 1366 |
|
|
2013
Q3 | $106K | Buy |
+7,122
| New | +$107K | ﹤0.01% | 975 |
|
Other funds holding MDRX
SPC
TCM
OFCM
MCM
CM
NRCM
PCMI
Canada Life's MDRX Position: Q1 2024 in Review
Canada Life sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 104,687 shares — an estimated $1.1M sold.
Canada Life first reported a position in MDRX in Q3 2013 and held it in 41 quarters. The position peaked at $2.45M in Q1 2022. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.
- Canada Life reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Canada Life sold 104,687 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $1.1M.
- Canada Life first reported a position in Veradigm Inc. Common Stock in Q3 2013 and held it in 41 quarters.
- Canada Life's Veradigm Inc. Common Stock position peaked at $2.45M in Q1 2022.
- 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.
Based on Canada Life's 13F filing for Q1 2024, filed 13 May 2024.